$LILY:CSE / $MPHMF Callitas Health, Inc. Signs
Post# of 53480
Callitas Health, Inc. Signs Licensing Agreement for Patented Arousal Gel w/ LifeStyles
CINCINNATI, OH & SOUTH ISELIN, NJ, June 26, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today that it has entered into a non-exclusive licensing and technology agreement with LifeStyles, LTD, the global leader in the sexual wellness sector, for its non-branded, patented arousal gel and lubricants for use on condoms and as a stand-alone product for retail and consumer markets around the world. For more information: http://www.thestreetnow.com/spotlight/mphmf/